Tradestie Institutional Equity Comparison Engine
FBRX vs BOLD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
FBRX Overall Edge
FBRX Captures Institutional Edge (3โ0 Pillars ยท 5โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Forte Biosciences, Inc. Common Stock (FBRX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, FBRX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus BOLD at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, FBRX sits in UNCLASSIFIED (3rd %ile IV; Dealer Gamma Walls on Pro) against BOLD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
FBRX N/M vs BOLD N/M Fwd P/E
Growth & Margin Winner
FBRX
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner
FBRX
1Y +580.4% vs +101.7% ยท 52W Pos 100% vs 62%
Options & Structure Winner
FBRX
UNCLASSIFIED (3rd %ile IV) vs UNCLASSIFIED (N/A IV)
FBRX
NASDAQ
Forte Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$76.99
+0.03% 1D
Market Cap
$1.6B
1M Return
+0.44%
1Y Return
+580.42%
Forward P/E
N/M
Unified AI Score
52.7 / 100
HOLD
Tech 49.0
Fund 51.0
Flow 62.0
Mom 40.0
BOLD
NASDAQ
Boundless Bio, Inc. Common Stock
Pharmaceutical Preparations
$2.32
-2.52% 1D
Market Cap
$56.2M
1M Return
-4.92%
1Y Return
+101.74%
Forward P/E
N/M
Unified AI Score
36.8 / 100
SELL
Tech 25.0
Fund 50.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
FBRX +580.42%
BOLD +101.74%
Spread: +158.01 pp (FBRX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
FBRX TTM Op. Margin: 0.0%
BOLD TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FBRX vs BOLD. Trailing 12-month operating profitability (FBRX 0.0% vs BOLD 0.0%) and valuation multiples (FBRX N/M vs BOLD N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | FBRX | BOLD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.6B | $56.2M | Larger Scale | FBRX |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -62.3% | -64.6% | Higher ROE | FBRX |
| 52-Week Range Position Momentum | 100% ($10โ$77) | 62% ($1โ$3) | Stronger Trend | FBRX |
| Beta / 30D Volatility Risk Regime | 1.09ฮฒ ยท 3% Vol | -0.08ฮฒ ยท 28% Vol | Lower Realized Risk | FBRX |
| Unified Institutional Score Composite Signal | 52.7 / 100 (HOLD) | 36.8 / 100 (SELL) | Higher Composite | FBRX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full FBRX vs BOLD Buy Guide
FBRX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
3rd %ile
IV Regime
Compressed (<25th %ile)
BOLD
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither FBRX nor BOLD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.